トマトの複数のシステム内フィトサイトキンを相殺する受容体アンタゴニスト
Lei Wang1, Louis-Philippe Maier2, Nga Pham3
1Yazhouwan National Laboratory, Sanya 572024, Hainan, China; ZMBP, University of Tübingen, Tübingen 72076, Germany; Institute of Plant Sciences, University of Bern, Bern 3013, Switzerland.
Cell
|August 22, 2025
まとめ
植物では抗SYSを用いて免疫刺激性フィトサイトカインを抑制し,免疫バランスを確保する. このペプチドは天然の抗生物質として作用し,トマトの成長と生殖健康に不可欠です.
科学分野:
- 植物生物学
- 分子植物病原体相互作用
- 植物免疫
背景:
- 植物における免疫活性化には 最適な健康状態を保つために 厳格な規制が必要です
- 植物が免疫刺激性フィトサイトカインを制御するメカニズムは完全に理解されていません.
- フィトサイトカインは植物の防御と発達に 重要な役割を果たします
研究 の 目的:
- トマトのサイトカインシステムインの天然阻害剤を特定する.
- 植物免疫反応の調節における antiSYS の役割を明らかにする.
- フィトサイトカインの活性調節剤としてのアンチSYSのメカニズムを理解する.
主な方法:
- アンチSYSをシステムインのようなペプチドとして識別する.
- システムイン受容体の特異的抗体としてのantiSYSの特徴
- 抗SYSを欠いたトマト変異体の分析により,表型的な影響を評価する.
主要な成果:
- AntiSYSはトマトのサイトカインシステムンの新しい阻害剤です.
- AntiSYSは,システムイン受容体の強力で特異的な抗体として作用する.
- 抗SYSを欠いたトマトの変異種は 異常な成長と生殖能力の低下を示します
結論:
- AntiSYSは,トマトの植物におけるフィトサイトカインの活性を調節するために不可欠です.
- 免疫ホメオスタシスを維持する.
- この発見は,全王国における免疫調節の保存されたメカニズムに関する洞察を提供します.
関連する概念動画
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cell Signaling in Plants
5.7K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.7K
Drug-Receptor Interaction: Antagonist
3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Combined Effects of Drugs: Antagonism
9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


